Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now early-phase tilt small index

Biliary Atresia: early-phase trial registry

6 of 8 indexed Biliary Atresia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 6 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Biliary Atresia: 8 US clinical trials tracked, 6 recruiting.

Biliary Atresia is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Arbor Research Collaborative for Health, running 2 of these trials.

Enrollment posture brief

Registry condition biliary-atresia

OPEN 6 | RECR 75% | LATE 1 | EARLY 2 | RANK #2176 | SPON 2

Nearest open-share peer: Adolescent Idiopathic Scoliosis (75% recruiting · 8 trials)

Activity, Motor75%Biliary Atresia (this)75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%
Open-enrollment share among volume-matched conditions near Biliary Atresia

Biliary Atresia lists 6 open slots (75% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Biliary Atresia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Biliary Atresia is recruiting above its size-band peers.

    6 of 8 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Biliary Atresia research.

    Arbor Research Collaborative for Health accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Biliary Atresia enrolment sits around 254 participants.

    Median target enrolment is 254 among the 8 trials that report a genuine target (sentinel values excluded). 2 of those (25%) plan for fewer than 100 participants.

  4. Biliary Atresia research leans observational.

    3 interventional and 5 observational studies make up this index (37.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 31

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 3 1

Named interventions

Most-linked intervention names on Biliary Atresia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Ultrasound Shear Wave Elastography Device
1 trials
Odevixibat Drug
1 trials
Oral Vancomycin Drug
1 trials
Indocyanine Green Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Biliary Atresia trials. A trial with sites in several states counts in each.

California 5 trials
New York 4 trials
Pennsylvania 3 trials
Ohio 3 trials
Missouri 3 trials
Maryland 3 trials
Indiana 3 trials
Illinois 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Biliary Atresia page

8 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Biliary Atresia condition card totals 8 registered trials; most-linked intervention Ultrasound Shear Wave Elastography; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.